Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|February 8, 2011
Ipilimumab: a promising immunotherapy for melanomaJaykumar R Thumar, Harriet M KlugerMedical Oncology (Northwood, London, England)|December 29, 2012
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicityKrishna S Gunturu, Xiaopan Yao, Xiangyu Cong, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanomaMatthew J Hadfield, Gracia MuiCancer Journal (Sudbury, Mass.)|March 25, 2024
What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?Matthew J Hadfield, Ryan J SullivanJournal of Osteopathic Medicine|November 20, 2021
Bursting the bubble: hereditary spherocytosis masking poor glycemic controlAshley Gordon, Deep Pachu, Matthew J HadfieldJournal of Personalized Medicine|April 25, 2025
Targeted Therapeutic Approaches for the Treatment of Cancer: The Future Is BrightMatthew J Hadfield, Benedito A Carneiro, Liang ChengJournal of the American Academy of Dermatology|August 25, 2024
Dermatologic toxicities of antibody-drug conjugatesChristian Gronbeck, Matthew J Hadfield, Jane M Grant-KelsMelanoma Research|June 27, 2020
Desmoplastic melanoma: an updated clinical review and the emerging role of genetic markers and immunotherapiesMatthew J Hadfield, Racquel Helsing, Jane M Grant-KelsCureus|September 10, 2019
Case of Anthracycline-induced Cardiogenic Shock: A Call to Optimize Modifiable Cardiac Risk Factors Prior to ChemotherapyAndre Gabriel, Bryan Stringer, Matthew J Hadfield, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 16, 2021
Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858RMatthew J Hadfield, Alla Turshudzhyan, Khalid Shalaby, et al.Pageof 4